• Home
• Asthma
  • Case studies
  • Inhaler techniques
  • Self management plans
  • Guidelines
  • Respiratory drugs – how they work
• Case studies
  • Grace: managing asthma in pregnancy
  • Jeremy: Managing a severe asthma attack in a child
  • Margaret: Managing COPD in a long-term smoker
  • Shilpa: Promoting concordance-ensuring correct inhaler technique in a patient with asthma
• COPD
  • Case studies
  • Guidelines
• Education for Health
  • Case studies
  • Respiratory drugs – how they work
  • Toolkit information
  • Education and training
  • Self management plans
  • Education for Health Products
• Guidelines
• Your feedback

Guidelines

In May 2008, British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) updated their joint 'British guideline on the management of asthma', originally published in 2003.

The BTS/SIGN asthma guideline is a 'live' guideline, and is continually updated. Bookmark this page so that you can re-visit it when the guideline is updated.

Authorised summaries of the BTS/SIGN guideline have been published in the handbook 'Guidelines – summarising clinical guidelines for primary care' and also on the eGuidelines.co.uk website. Click on the links below to view the summaries:

• British guideline on the management of asthma in adults
• British guideline on the management of asthma in children.

Alternatively, you can download PDFs of the full BTS/SIGN guideline:

• Click here to download PDFs of the full guideline and/or quick reference guide from the SIGN website.

The Real website is supported by Teva UK Limited. Teva UK Limited has had the opportunity to comment on the medical content and accuracy of this website, however, final editorial control resides with the contributors and MGP Ltd. The views and opinions of the contributors to the website are not necessarily those of Teva UK Limited. Click here for Qvar® (CFC-free beclometasone dipropionate) prescribing information. Qvar® 50mcg and Qvar® 100mcg is licensed for adults including the elderly. To date there is no data in children under 12 years of age, hence no definitive dosage recommendation can be made.
MED/10/212. Date of preparation: March 2010. © 2010 MGP Ltd